SLC17A1
Sodium-dependent phosphate transport protein 1
Also known as: NAPI-1, NPT1, NPT1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14916
- Gene
- SLC17A1
- Ensembl
- ENSG00000124568
- Chromosome
- 6
- Canonical length
- 467 aa
- Protein class
- Metabolic proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
Predicted to enable transmembrane transporter activity. Involved in sodium-dependent phosphate transport; urate metabolic process; and urate transport. Located in apical plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
467 residues, UniProt reviewed canonical sequence.
>Q14916|SLC17A1
1 MQMDNRLPPK KVPGFCSFRY GLSFLVHCCN VIITAQRACL NLTMVVMVNS TDPHGLPNTS
61 TKKLLDNIKN PMYNWSPDIQ GIILSSTSYG VIIIQVPVGY FSGIYSTKKM IGFALCLSSV
121 LSLLIPPAAG IGVAWVVVCR AVQGAAQGIV ATAQFEIYVK WAPPLERGRL TSMSTSGFLL
181 GPFIVLLVTG VICESLGWPM VFYIFGACGC AVCLLWFVLF YDDPKDHPCI SISEKEYITS
241 SLVQQVSSSR QSLPIKAILK SLPVWAISTG SFTFFWSHNI MTLYTPMFIN SMLHVNIKEN
301 GFLSSLPYLF AWICGNLAGQ LSDFFLTRNI LSVIAVRKLF TAAGFLLPAI FGVCLPYLSS
361 TFYSIVIFLI LAGATGSFCL GGVFINGLDI APRYFGFIKA CSTLTGMIGG LIASTLTGLI
421 LKQDPESAWF KTFILMAAIN VTGLIFYLIV ATAEIQDWAK EKQHTRLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC17A1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 158 nTPM
Expression across tissuesHPA
Tissue
- kidney: 158 nTPM
- liver: 46 nTPM
- testis: 2 nTPM
- adrenal gland: 0.2 nTPM
- cerebral cortex: 0.1 nTPM
- colon: 0.1 nTPM
Single-cell type
- proximal tubule cells: 1,150 nCPM
- hepatocytes: 35 nCPM
- early spermatids: 33 nCPM
- renal connecting tubule cells: 30 nCPM
- distal convoluted tubule cells: 24 nCPM
- podocytes: 23 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.37
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.42
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- monoatomic ion transport
- phosphate ion transmembrane transport
- phosphate ion transport
- sodium-dependent phosphate transport
- urate metabolic process
- urate transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Major facilitator superfamily
- Major facilitator superfamily domain
- MFS transporter superfamily
- Major Facilitator Superfamily Sodium/Anion Cotransporter
- Major Facilitator Superfamily
- Na-dependent inorganic phosphate cotransporter
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SLC17A1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC17A1 as an antibody target. Whether an autoantibody or antibody against SLC17A1 could matter depends on whether native SLC17A1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC17A1 is annotated at the cell surface, where native SLC17A1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC17A1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...